Get my own profile
Public access
View all12 articles
1 article
available
not available
Based on funding mandates
Co-authors
- Brad H NelsonDirector, Deeley Research Centre, BC Cancer AgencyVerified email at bccancer.bc.ca
- Robert A. HoltHead of Sequencing, Michael Smith Genome Sciences Centre, BC Cancer Agency Distinguished ScientistVerified email at bcgsc.ca
- Darin A. WickDeeley Research Centre, BC Cancer AgencVerified email at wick.ca
- Katey SS EnfieldFrancis Crick Institute, London, UKVerified email at crick.ac.uk
- Wan L. LamBC Cancer Research Centre; University of British ColumbiaVerified email at bccrc.ca
- Julie S. NielsenLeader, Cell Manufacturing, BC Cancer's Immunotherapy ProgramVerified email at bccancer.bc.ca
- Scott Derek BrownResearch Associate, BC Cancer Research InstituteVerified email at bcgsc.ca
- john webbBritish Columbia Cancer Agency / Deeley Research CentreVerified email at bccrc.ca
- Erin A Marshall, PhDUniversity of British Columbia (BC Cancer Research Centre)Verified email at bccrc.ca
- Peter H WatsonBC CancerVerified email at bccancer.bc.ca
- Kwame Twumasi-BoatengTelix PharmaceuticalsVerified email at telixpharma.com
- David KroegerAssociate Director BD, Zymeworks Inc.Verified email at usask.ca
- RL WarrenGenome Sciences Centre, BC CancerVerified email at bcgsc.ca
- Nathaniel R WestGenentechVerified email at gene.com
- Mauro CastellarinResearch Associate, University of Pennsylvania, Center for Cellular ImmunotherapiesVerified email at pennmedicine.upenn.edu
- George CoukosUniversity Hospital of Lausanne, Ludwig Institute for Cancer ResearchVerified email at chuv.ch
- Ewan A GibbIndependent Researcher
Follow
Spencer D. Martin, MD PhD
Faculty of Medicine, University of British columbia
Verified email at vch.ca